| Literature DB >> 27366228 |
Claire Zar-Kessler1, Amel Karaa2, Katherine Bustin Sims3, Virginia Clarke3, Braden Kuo4.
Abstract
Fabry disease is a rare X-linked lysosomal storage disease characterized by the dysfunction of multiple systems, including significant gastrointestinal involvement such as diarrhea, abdominal pain, early satiety and nausea. The gastrointestinal symptoms of Fabry disease are thought to be due to neuropathic and myopathic changes leading to symptoms of dysmotility that are encountered in many other disorders. The gastrointestinal symptoms can often be one of the presenting signs of the disease in childhood, but can be misdiagnosed by gastroenterologists for many years due to their nonspecific presentation. As the chief treatment for Fabry is enzyme-replacement therapy that has been shown to stabilize and possibly reverse disease course, recognition of these symptoms and early diagnosis in an attempt to prevent progression with treatment, is critical.Entities:
Keywords: abdominal pain; diarrhea; lysosomal storage disease; neuropathy
Year: 2016 PMID: 27366228 PMCID: PMC4913334 DOI: 10.1177/1756283X16642936
Source DB: PubMed Journal: Therap Adv Gastroenterol ISSN: 1756-283X Impact factor: 4.409